Acute Caffeine Ingestion on Futsal Performance

Caffeine Clinical Trial

— CAFFFUTSAL  

Official title:

Effects of Acute Caffeine Ingestion on Futsal Performance in Sub-elite Players

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04852315
• Other study ID #: Universidad Francisco Vitoria
• Status: Completed
• Phase: N/A
• Start date: October 16, 2019
• Est. completion date: October 18, 2019

Study information

• Verified date: April 2021
• Source: Universidad Francisco de Vitoria
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Caffeine supplementation has been recognized such as an useful strategy for improving performance in intermittent sports, however caffeine ingestion in futsal has been barely studied. In this randomized placebo-controlled study, we investigated the effects of acute caffeine supplementation in improving neuromuscular performance and physical match activity in futsal players.

Description:

To date, no previous investigation has studied the effect of acute caffeine ingestion on futsal performance during futsal-specific testing and during a simulated match. Therefore, the aim of this investigation was to establish the effects of acute caffeine intake on futsal-specific tests (e.g. futsal kicking velocity) and match-play running performance in male futsal players.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 16
• Est. completion date: October 18, 2019
• Est. primary completion date: October 18, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 35 Years

Eligibility

Inclusion Criteria:

• Sub-elite men futsal players

Exclusion Criteria:

• Intolerance to caffeine,
• Suffering from any chronic pathology or an injury in the month prior to the investigation
• Use of medicines or dietary supplements during the study.

Related Conditions & MeSH terms

• Caffeine
• Placebo

Intervention

Dietary Supplement:
• Caffeine
Gelatine capsule with caffeine (3 mg/kg body mass of caffeine) (Bulk Powders, London, United Kingdom). The capsule containing the treatment was ingested with 150 mL of water 60 minutes before the onset of the experiment to allow substance absorption.
• Placebo
Gelatine capsule with placebo (Cellulose; Guinama, Valencia, Spain). The capsule containing the treatment was ingested with 150 mL of water 60 minutes before the onset of the experiment to allow substance absorption.

Locations

Country	Name	City	State
Spain	Universidad Francisco de Vitoria	Madrid

Sponsors (4)

Lead Sponsor	Collaborator
Universidad Francisco de Vitoria	Universidad Miguel Hernandez de Elche, Universidad Rey Juan Carlos, University of Beira Interior

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes in futsal match-play demands (m/min)	Using a wireless inertial movement unit system	48-hours
Secondary	Changes in maximal jump height (cm)	Infrared beam jump system	48-hours
Secondary	Changes in 20-m sprint test (s)	Time to complete 10-m and 20-m sprints using photocell timing gates	48-hours
Secondary	Futsal kicking velocity and accuracy test (km/h)	Throwing velocity using a radar gun	48-hours